RNU7-113P

Across TCGA pan-cancer cohorts, RNU7-113P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU7-113P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where RNU7-113P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-113P is over-expressed in tumor.

CHOL, BLCA, and LIHC are the cancer types where RNU7-113P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-113P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	+1.110	<.001	4	view →
BLCA	Female	All	+0.633	.025	4	view →
LIHC	All	All	+0.142	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU7-113P–CHOL

Open the CHOL breakdown →